Back
Aurinia Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
AUPH
Sponsored
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
36
AUPH
Aurinia Pharmaceuticals
Last Price:
5.09
Seasonality Move:
-6.08%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!Aurinia Pharmaceuticals Price Quote
$5.09
+0.08 (+1.6%)
(Updated: April 30, 2024 at 11:25 AM ET)
Aurinia Pharmaceuticals Key Stats
Sell
36
Aurinia Pharmaceuticals (AUPH)
is a Sell
Day range:
$4.92 - $5.07
52-week range:
$4.71 - $12.43
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.08
P/B ratio:
1.92%
Volume:
939.2K
Avg. volume:
1.3M
1-year change:
-55.47%
Market cap:
$724.5M
Revenue:
$175.5M
EPS:
$-0.53
How Much Does Aurinia Pharmaceuticals Make?
-
How Much Are Aurinia Pharmaceuticals's Sales Annually?
AUPH Revenues are $175.5M -
How Much Profit Does Aurinia Pharmaceuticals's Make A Year?
AUPH net income is -$78M
Is Aurinia Pharmaceuticals Growing As A Company?
-
What Is Aurinia Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.59% -
What Is Aurinia Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aurinia Pharmaceuticals Stock Price Performance
-
Did Aurinia Pharmaceuticals Stock Go Up Last Month?
Aurinia Pharmaceuticals share price went up by 0% last month -
Did AUPH's Share Price Rise Over The Last Year?
AUPH share price fell by -55.47% over the past 1 year
What Is Aurinia Pharmaceuticals 52-Week High & Low?
-
What Is Aurinia Pharmaceuticals’s 52-Week High Share Price?
Aurinia Pharmaceuticals has traded as high as $12.43 over the past 52 weeks -
What Is Aurinia Pharmaceuticals’s 52-Week Low Share Price?
Aurinia Pharmaceuticals has traded as low as $4.71 over the past 52 weeks
Aurinia Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aurinia Pharmaceuticals?
-
How Much Debt Does Aurinia Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aurinia Pharmaceuticals Have?
Cash and short term investments quarterly total is $350.5M -
What Is Aurinia Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.63
Is Aurinia Pharmaceuticals Cash Flow Positive?
-
What Is AUPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$33.5M -
What Is Aurinia Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$5.1M -
What Is Aurinia Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6.7M
Aurinia Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
AUPH return on invested capital is -19.92% -
What Is Aurinia Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -15.15% -
What Is AUPH Return On Equity?
ROE is a measure of profitability and is -19.92%
Aurinia Pharmaceuticals Earnings Date & Stock Price
-
What Is Aurinia Pharmaceuticals's Stock Price Today?
A single share of AUPH can be purchased today for 5.01 -
What Is Aurinia Pharmaceuticals’s Stock Symbol?
Aurinia Pharmaceuticals trades on the nasdaq under the ticker symbol: AUPH -
When Is Aurinia Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Aurinia Pharmaceuticals is scheduled on May 2, 2024 -
When Is AUPH's next ex-dividend date?
Aurinia Pharmaceuticals's next ex-dividend date is July 16, 2020 -
How To Buy Aurinia Pharmaceuticals Stock?
You can buy Aurinia Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aurinia Pharmaceuticals Competitors
-
Who Are Aurinia Pharmaceuticals's Competitors?
Below is a list of companies who compete with Aurinia Pharmaceuticals or are related in some way:
Aurinia Pharmaceuticals Dividend Yield
Data Unavailable
Aurinia Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -16.33% |
Revenue: | 58.59% | -0.14% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 10.57 |
Upside from Last Price: | 111.01% |